XT
PASW

XTX Topco’s Ping An Biomedical PASW Stock Holding History

XTX Topco’s Portfolio PASW Stock Details PASW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.3K Sell
134,558
-1,869
-1% -$301 ﹤0.01% 3884
2026
Q1 		$18K Buy
136,427
+113,348
+491% +$23.7K ﹤0.01% 3576
2025
Q4 		$11.6K Buy
+23,079
New +$15.4K ﹤0.01% 3164

Other funds holding PASW

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

XTX Topco's PASW Position: Q2 2026 in Review

XTX Topco reduced its Ping An Biomedical (PASW) stake by 1.4% in Q2 2026, selling an estimated $301 and leaving 134,558 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3884.

XTX Topco first reported a position in PASW in Q4 2025 and has held it in 3 quarters since. 4 funds tracked by Wall St. Rank hold PASW as of Q2 2026.

  • XTX Topco held 134,558 shares of Ping An Biomedical worth $22.3K as of Q2 2026.
  • XTX Topco sold 1,869 Ping An Biomedical shares in Q2 2026, an estimated $301.
  • Ping An Biomedical made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3884 holding.
  • XTX Topco first reported a position in Ping An Biomedical in Q4 2025 and has held it in 3 quarters since.
  • 4 funds tracked by Wall St. Rank held Ping An Biomedical as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.